title: Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
authors.affiliation: Department of Surgery, Georgetown University Hospital, Washington, DC 20007.
authors.forename: M L
authors.initials: ML
authors.lastname: Foegh
authors.forename: K
authors.initials: K
authors.lastname: Lim
authors.forename: F
authors.initials: F
authors.lastname: Douglas
authors.forename: J
authors.initials: J
authors.lastname: Turk
authors.forename: G B
authors.initials: GB
authors.lastname: Helfrich
authors.forename: S A
authors.initials: SA
authors.lastname: Taher
authors.forename: M R
authors.initials: MR
authors.lastname: Alijani
mesh_terms: D003864:Depression, Chemical; D006084:Graft Rejection; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016030:Kidney Transplantation; D011725:Pyridines / Q000494:pharmacology* / Q000627:therapeutic use; D013929:Thromboxane B2 / Q000032:analysis*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
chemical_list: D007093:Imidazoles; D007166:Immunosuppressive Agents; D011725:Pyridines; D013929:Thromboxane B2; C037787:pirmagrel; D013930:Thromboxane-A Synthase